From the Conference Q/A -Old Tollovir data to b
Post# of 30028
(Total Views: 293)
Posted On: 07/09/2021 1:34:37 AM
.jpg)
From the Conference Q/A
-Old Tollovir data to be put out in next couple months
-Tollovir/Tollotest P2 recruitment in Israel was slow, but has picked up, Data Q3 or early Q4
-Start India Trial in August, finish early Q4, broader data set hospitalized and non-hospitalized
-Robust Phase 3 to start in Q4
-EUA's could follow quickly
-Todos has engaged NDA partners to take a crack at the Antiviral Task Force $3.2B, but need to file IND in US
-Working to get Videssa back in lab in Q4, which will enable commercialization
-May conduct additional Videssa studies in younger women
-Separate Crowdfunding action for a separate Tollovid entity
-Investor Relations firms are being engaged.
-Active discussions with Nasdaq. Strong support from existing Institutional investors
-Revenue coming in on Provista PCR testing, expect Q3
-Debt will convert to equity at uplist
Same old blah blah blah company not focused, investors just don't get how much we have going on.
-Old Tollovir data to be put out in next couple months
-Tollovir/Tollotest P2 recruitment in Israel was slow, but has picked up, Data Q3 or early Q4
-Start India Trial in August, finish early Q4, broader data set hospitalized and non-hospitalized
-Robust Phase 3 to start in Q4
-EUA's could follow quickly
-Todos has engaged NDA partners to take a crack at the Antiviral Task Force $3.2B, but need to file IND in US
-Working to get Videssa back in lab in Q4, which will enable commercialization
-May conduct additional Videssa studies in younger women
-Separate Crowdfunding action for a separate Tollovid entity
-Investor Relations firms are being engaged.
-Active discussions with Nasdaq. Strong support from existing Institutional investors
-Revenue coming in on Provista PCR testing, expect Q3
-Debt will convert to equity at uplist
Same old blah blah blah company not focused, investors just don't get how much we have going on.
(1)
(0)Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼